These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Poison ivy (Rhus toxicodendron); a survey of the poison ivy problem in Canada and some independent observations on the value of zirconium products in prophylaxis and treatment. CASPERS AP. Can Med Assoc J; 1957 May 15; 76(10):852-60. PubMed ID: 13426931 [No Abstract] [Full Text] [Related]
6. ATTEMPTS TO HYPOSENSITIZE WITH POISON IVY EXTRACTS. KANOF NB, BAER RL. Ann Allergy; 1964 Apr 15; 22():161-4. PubMed ID: 14145236 [No Abstract] [Full Text] [Related]
7. Prevention of poison ivy dermatitis with oral homeopathic Rhus toxicodendron. Signore RJ. Dermatol Online J; 2017 Jan 15; 23(1):. PubMed ID: 28329482 [Abstract] [Full Text] [Related]
18. Newer concepts and developments concerning poison ivy and allied conditions. PROKESCH CE. Arch Pediatr (N Y); 1950 Jun 15; 67(6):267-79. PubMed ID: 15426524 [No Abstract] [Full Text] [Related]
19. Racial and environmental factors in susceptibility to Rhus. CLAIBORNE ER, EPSTEIN E. AMA Arch Derm; 1957 Feb 15; 75(2):197-201. PubMed ID: 13393788 [No Abstract] [Full Text] [Related]